A single-blind crossover trial of the anti-inflammatory drug sodium meclofenamate and placebo, including an evaluation of hand grip and of lymphocyte responsiveness.

@article{Palmer1981ASC,
  title={A single-blind crossover trial of the anti-inflammatory drug sodium meclofenamate and placebo, including an evaluation of hand grip and of lymphocyte responsiveness.},
  author={Donald George Palmer and Gil O Barbezat and B. L. Gibbins and David Michael Grennan and John Bernard Lum and D. Brenton Myers and Katie Wilson},
  journal={Current medical research and opinion},
  year={1981},
  volume={7 6},
  pages={
          359-69
        }
}
A single-blind crossover trial was carried out in 21 patients with active rheumatoid arthritis to assess the effectiveness and tolerance of sodium meclofenamate (300 mg per day) compared with placebo. After a 1-week washout period patients had two periods of active medication, each of 2 weeks, separated by 1 week on placebo. Morning stiffness, walking speed, pain score, patient impression of response, joint tenderness and power, work and maximum grip strength achieved by hand grip were all… CONTINUE READING